Post-therapeutic tissue is bradytrophic and thus has low perfusion values in PCT. In contrast, malignant tissue is expected to show higher perfusion values as cancer growth partially depends on angiogenesis.
OBJECTIVES:
This prospective study investigates perfusion computed tomography (PCT) for the post-therapeutic detection of cancer in the head and neck region.
METHODS:
85 patients underwent PCT for 1) initial work-up of head and neck cancer (HNC; n=22) or 2) for follow-up (n=63). Regions of interest (ROIs) were placed in confirmed tumour, a corresponding location of benign tissue, and reference tissue. Perfusion was calculated using a single input maximum slope algorithm. Statistical analysis was performed with the Mann-Whitney U-test.
RESULTS:
PCT allowed significant differentiation of malignant tissue from post-therapeutic tissue after treatment for HNC (p=0.018). Significance was even greater after normalization of perfusion values (p=0.007). PCT allowed highly significant differentiation of HNC from reference tissue (p<0.001).
CONCLUSIONS:
PCT provides significantly distinct perfusion values for malignant and benign as well as post-therapeutically altered tissue in the head and neck area, thus allowing differentiation of cancer from healthy tissue. Our results show that PCT in conjunction with a standard algorithm is a potentially powerful HNC diagnostic tool.
FerlayJ, SoerjomataramI, DikshitR, EserS, MathersC, RebeloM, et al.Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012. Int J Cancer. 2015;136(5):E359–86.
2.
PredaL, CalloniSF, MoscatelliMEM, Cossu RoccaM, BellomiM. Role of CT Perfusion in Monitoring and Prediction of Response to Therapy of Head and Neck Squamous Cell Carcinoma. BioMed Res Int. 2014;2014:1–8.
3.
RiveraC. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884–94.
4.
van MonsjouHS, BalmAJM, van den BrekelMM, WreesmannVB. Oropharyngeal squamous cell carcinoma: A unique disease on the rise?Oral Oncol. 2010;46(11):780–5.
5.
ConleyBA. Treatment of Advanced Head and Neck Cancer: What Lessons Have We Learned?J Clin Oncol. 2006;24(7):1023–5.
6.
Lo NigroC, DenaroN, MerlottiA, MerlanoM. Head and neck cancer: improving outcomes with a multidisciplinary approach. Cancer Manag Res. 2017;9:363–71.
7.
ShahGV, WesolowskiJR, AnsariSA, MukherjiSK. New directions in head and neck imaging. J Surg Oncol. 2008;97(8):644–8.
8.
AhmadA, BranstetterBF. CT Versus MR: Still a Tough Decision. Otolaryngol Clin North Am. 2008;41(1):1–22.
9.
BisdasS, MedovL, BaghiM, KonstantinouGN, WagenblastJ, ThngCH, et al.A comparison of tumour perfusion assessed by deconvolution-based analysis of dynamic contrast-enhanced CT and MR imaging in patients with squamous cell carcinoma of the upper aerodigestive tract. Eur Radiol. 2008;18(4):843–50.
10.
EmontsP, BourgeoisP, LemortM, FlamenP. Functional imaging of head and neck cancers. Curr Opin Oncol. 2009;21(3):212–7.
11.
RumboldtZ, Al-OkailiR, DeveikisJP. Perfusion CT for head and neck tumors: pilot study. AJNR Am J Neuroradiol. 2005;26(5):1178–85.
12.
FrankJL, GarbJL, KayS, McClishDK, BethkeKP, LindDS, et al.Postoperative radiotherapy improves survival in squamous cell carcinoma of the hypopharynx. Am J Surg. 1994;168(5):476–80.
13.
BrocksteinB. Benefits of chemotherapy in head and neck cancer. The Lancet. 2000;356(9231):767.
14.
CarlaC, DarisF, CeciliaB, FrancescaB, FrancescaC, PaoloF. Angiogenesis in Head and Neck Cancer: A Review of the Literature. J Oncol. 2012;2012:1–9.
15.
HanH, JiZ, DingH, ZhangW, ZhangR, WangW. Assessment of blood flow in the hepatic tumors using non-contrast micro flow imaging: Initial experience. Clin Hemorheol Microcirc. 2019;73(2):307–16.
16.
TrojanowskaA, TrojanowskiP, DropA, Jargieł łoT, KlatkaJ. Head and neck cancer: value of perfusion CT in depicting primary tumor spread. Med Sci Monit Int Med J Exp Clin Res. 2012;18(2):CR112–118.
17.
MilesKA, LeeT-Y, GohV, KlotzE, CuenodC, BisdasS, et al.Current status and guidelines for the assessment of tumour vascular support with dynamic contrast-enhanced computed tomography. Eur Radiol. 2012;22(7):1430–41.
18.
BeerL, PolanecSH, BaltzerPAT, SchatzlG, GeorgD, SchestakC, et al.4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study. PloS One. 2019;14(12):e0225673.
19.
SunZ, HuS, LiJ, WangT, XieZ, JinL. An application study of CT perfusion imaging in assessing metastatic involvement of perigastric lymph nodes in patients with T1 gastric cancer. Br J Radiol. 2020;93(1106):20190790.
20.
CindilE, ErbasG, AkkanK, CeritMN, SendurHN, ZorMH, et al. Dynamic Volume Perfusion CT of the Foot in Critical Limb Ischemia: Response to Percutaneous Revascularization. Am J Roentgenol. 2020;1-11.
21.
RanaL, SharmaS, SoodS, SinghB, GuptaMK, MinhasRS, et al.Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy. Eur J Radiol Open. 2015;2:46–54.
22.
RazekAAKA, TawfikAM, ElsorogyLGA, SolimanNY. Perfusion CT of head and neck cancer. Eur J Radiol. 2014;83(3):537–44.
23.
UrsinoS, FaggioniL, GuidoccioF, FerrazzaP, SecciaV, NeriE, et al.Role of perfusion CT in the evaluation of functional primary tumour response after radiochemotherapy in head and neck cancer: preliminary findings. Br J Radiol. 2016;89(1065):20151070.
24.
GandhiD, ChepehaDB, MillerT, CarlosRC, BradfordCR, KaramchandaniR, et al.Correlation between initial and early follow-up CT perfusion parameters with endoscopic tumor response in patients with advanced squamous cell carcinomas of the oropharynx treated with organ-preservation therapy. AJNR Am J Neuroradiol. 2006;27(1):101–6.
25.
PetraliaG, PredaL, GiuglianoG, Jereczek-FossaBA, RoccaA, D’AndreaG, et al.Perfusion computed tomography for monitoring induction chemotherapy in patients with squamous cell carcinoma of the upper aerodigestive tract: correlation between changes in tumor perfusion and tumor volume. J Comput Assist Tomogr. 2009;33(4):552–9.
26.
TruongMT, SaitoN, OzonoffA, WangJ, LeeR, QureshiMM, et al.Prediction of locoregional control in head and neck squamous cell carcinoma with serial CT perfusion during radiotherapy. AJNR Am J Neuroradiol. 2011;32(7):1195–201.
27.
HermansR, MeijerinkM, Van den BogaertW, RijndersA, WeltensC, LambinP. Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy. Int J Radiat Oncol Biol Phys. 2003;57(5):1351–6.
28.
MukherjiSK, CastelijnsJA. CT perfusion of head and neck cancer: why we should care versus why should we care!AJNR Am J Neuroradiol. 2010;31(3):391–3.
29.
Bundesamt für Strahlenschutz. Diagnostische Referenzwerte für diagnostische und interventionelle Röntgenanwendungen. 2016.
30.
LambyP, Krüger-GengeA, FrankeRP, MrowietzC, FalterJ, GrafS, et al.Effect of iodinated contrast media on the oxygen tension in the renal cortico-medullary region of pigs. Wiggermann P, Krüger-Genge A, Jung F, editors. Clin Hemorheol Microcirc. 2019;73(1):261–70.
31.
LambyP, MinkowA, HandtS, FalterJ, SchellenbergE-L, GrafS, et al.Histological and SEM Assessment of Blood Stasis in Kidney Blood Vessels after Repeated Intra-Arterial Application of Radiographic Contrast Media. Life. 2020;10(9):167.
32.
NguyenTB, CronGO, BezzinaK, PerdrizetK, TorresCH, ChakrabortyS, et al.Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas. AJNR Am J Neuroradiol. 2016;37(12):2217–23.
33.
GulaniV, CalamanteF, ShellockFG, KanalE, ReederSB. International Society for Magnetic Resonance in Medicine. Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017;16(7):564–70.
